Free Trial

Wells Fargo & Company's Rating of Amphastar Pharmaceuticals on 11/22/2024

On November 22, 2024, Wells Fargo & Company updated its outlook on Amphastar Pharmaceuticals (NASDAQ:AMPH) with the action "Initiated Coverage", setting a "Equal Weight" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.